文献速递关节外科

下一代测序与培养法诊断全膝关节置换术后假体周围关节感染的比较:成本-效果分析

Next-Generation Sequencing vs Culture-Based Methods for Diagnosing Periprosthetic Joint Infection After Total Knee Arthroplasty: A Cost-Effectiveness Analysis.
PubMed 文献 · J Arthroplasty · 2019-03-19

本研究采用马尔可夫状态转换模型,从社会视角模拟全膝关节置换术后假体周围关节感染(PJI)诊断中下一代测序(NGS)与培养法的终身成本与质量调整生命年(QALY)。基础分析显示培养法相比NGS的增量成本-效果比为每QALY 422,784美元,NGS在PJI检验前概率高于45.5%时具成本-效果,且当NGS灵敏度大于70.0%和特异度大于94.1%时具成本-效果。作者认为NGS的成本-效果主要取决于PJI检验前概率和NGS技术性能特征,NGS应保留用于检验前概率高的临床情境。

要点

  • 基础分析中培养法相比NGS的增量成本-效果比为每QALY 422,784美元。
  • NGS在PJI检验前概率高于45.5%时具成本-效果。
  • NGS灵敏度大于70.0%且特异度大于94.1%时具成本-效果。

核心结论

  • 模型结果提示NGS诊断PJI的成本-效果主要取决于PJI的检验前概率和NGS技术的性能特征。
  • 结果与NGS应保留用于PJI检验前概率高的临床情境这一观点一致。
  • 需进一步研究以确定NGS提供临床获益的适应证和亚组。

研究设计与样本

  • 构建马尔可夫状态转换模型,从社会视角预测终身成本和QALY,以确定成本-效果。
  • 主要结局为增量成本-效果比,支付意愿阈值为每QALY 100,000美元。
  • 进行敏感性分析以评估参数假设。

主要发现

  • 在基础病例值下,培养法相比NGS未被确定为具成本-效果,增量成本-效果比为每QALY 422,784美元。
  • 单因素敏感性分析发现,NGS在PJI检验前概率高于45.5%时是具成本-效果的选择。
  • NGS在其灵敏度大于70.0%且特异度大于94.1%时具成本-效果。
  • 双因素敏感性分析显示,检验前概率和检验性能参数(灵敏度和特异度)是判断特定策略是否具成本-效果的最大因素。

关键数值与推荐

  • 支付意愿阈值为每QALY 100,000美元。
  • NGS具成本-效果的PJI检验前概率阈值为高于45.5%。
  • NGS具成本-效果的灵敏度阈值为大于70.0%,特异度阈值为大于94.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究以确定NGS提供临床获益的适应证和亚组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection (PJI) after total knee arthroplasty is challenging to diagnose. Compared with culture-based techniques, next-generation sequencing (NGS) is more sensitive for identifying organisms but is also less specific and more expensive. To date, there has been no study comparing the cost-effectiveness of these two methods to diagnose PJI after total knee arthroplasty. METHODS: A Markov, state-transition model projecting lifetime costs and quality-adjusted life years (QALYs) was constructed to determine the cost-effectiveness from a societal perspective. The primary outcome was incremental cost-effectiveness ratio, with a willingness-to-pay threshold of $100,000/QALY. Sensitivity analyses were performed to evaluate parameter assumptions. RESULTS: At our base case values, culture was not determined to be cost-effective compared to NGS, with an incremental cost-effectiveness ratio of $422,784 per QALY. One-way sensitivity analyses found NGS to be the cost-effective choice above a pretest probability of 45.5% for PJI. In addition, NGS was cost-effective if its sensitivity was greater than 70.0% and its specificity greater than 94.1%. Two-way sensitivity analyses revealed that the pretest probability and test performance parameters (sensitivity and specificity) were the largest factors for identifying whether a particular strategy was cost-effective. CONCLUSION: The results of our model suggest that the cost-effectiveness of NGS to diagnose PJI depends primarily on the pretest probability of PJI and the performance characteristics of the NGS technology. Our results are consistent with the idea that NGS should be reserved for clinical contexts with a high pretest probability of PJI. Further study is required to determine the indications and subgroups for which NGS offers clinical benefit.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Torchia MT, Austin DC, Kunkel ST, et al. Next-Generation Sequencing vs Culture-Based Methods for Diagnosing Periprosthetic Joint Infection After Total Knee Arthroplasty: A Cost-Effectiveness Analysis. J Arthroplasty. 2019. PMID: 31005439. doi:10.1016/j.arth.2019.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。